Used as a reagent in Suzuki-Miyaura cross-coupling reactions, enabling the formation of carbon-carbon bonds in organic synthesis. Its strained bicyclic structure facilitates unique reactivity and selectivity, particularly in the construction of complex organic molecules such as pharmaceuticals and agrochemicals. The trifluoroborate group provides enhanced stability and ease of handling compared to traditional boronic acids, making it suitable for late-stage functionalization in drug development. It is especially valuable when introducing bridged cycloalkyl motifs that improve metabolic stability and bioavailability in bioactive compounds.